For research teamsHelp me find a study
Back to all studies
CompletedNCT06254612

SP-624 for depression

This study is completed in the United States. It is testing SP-624 for depression.

DepressionDrugFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether the Efficacy and Safety of SP-624 may be useful for adults experiencing depression.

What would participation involve?

Participants may receive the Efficacy and Safety of SP-624, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with depression.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: March 25, 2024
Recruitment status
Completed
Enrollment listed in the registry
497
Sponsor
Sirtsei Pharmaceuticals, Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06254612
Official title
A Multi-center, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT06254612. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 50 sites
  • IMA Clinical Research
    Phoenix, Arizona
    Site status: Not listed — confirm with the team
  • Noble Clinical Research
    Tucson, Arizona
    Site status: Not listed — confirm with the team
  • SanRo Clinical Research Group
    Bryant, Arkansas
    Site status: Not listed — confirm with the team
  • Clinical Innovations
    Bellflower, California
    Site status: Not listed — confirm with the team
  • Sun Valley Research Center
    Imperial, California
    Site status: Not listed — confirm with the team
  • Synergy San Diego
    Lemon Grove, California
    Site status: Not listed — confirm with the team
  • Excell Research
    Oceanside, California
    Site status: Not listed — confirm with the team
  • CiTrials
    Riverside, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Research
    Torrance, California
    Site status: Not listed — confirm with the team
  • Sunwise Clinical Research
    Walnut Creek, California
    Site status: Not listed — confirm with the team
  • Next Level Clinical Trials
    West Covina, California
    Site status: Not listed — confirm with the team
  • MCB Clinical Research Centers
    Colorado Springs, Colorado
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Accel Clinical
    Lakeland, Florida
    Site status: Not listed — confirm with the team
  • Segal Trials
    Lauderhill, Florida
    Site status: Not listed — confirm with the team
  • Segal Trials - Miami Lakes
    Miami Lakes, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • DMI Research
    Pinellas Park, Florida
    Site status: Not listed — confirm with the team
  • Accelerated Enrollment Solutions
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Velocity Clinical Research
    Meridian, Idaho
    Site status: Not listed — confirm with the team
  • Revive Research Institute
    Elgin, Illinois
    Site status: Not listed — confirm with the team
  • Tandem Clinical Research
    Marrero, Louisiana
    Site status: Not listed — confirm with the team
  • Boston Clinical Trials
    Boston, Massachusetts
    Site status: Not listed — confirm with the team
  • Neurobehavioral Medicine Group
    Bloomfield Hills, Michigan
    Site status: Not listed — confirm with the team
  • Midwest Research Group
    Saint Charles, Missouri
    Site status: Not listed — confirm with the team
  • Alivation Research
    Lincoln, Nebraska
    Site status: Not listed — confirm with the team
  • IMA Clinical Research
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Redbird Research
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Center for Emotional Fitness
    Cherry Hill, New Jersey
    Site status: Not listed — confirm with the team
  • CenExel HRI
    Marlton, New Jersey
    Site status: Not listed — confirm with the team
  • IMA Clinical Research
    Albuquerque, New Mexico
    Site status: Not listed — confirm with the team
  • Integrative Clinical Trials
    Brooklyn, New York
    Site status: Not listed — confirm with the team
  • Pioneer Clinical Research
    New York, New York
    Site status: Not listed — confirm with the team
  • Magnolia Clinical Research
    Cary, North Carolina
    Site status: Not listed — confirm with the team
  • UNC Chapel Hill
    Chapel Hill, North Carolina
    Site status: Not listed — confirm with the team
  • New Hope Clinical Research
    Charlotte, North Carolina
    Site status: Not listed — confirm with the team
  • Velocity Clinical Research
    Beachwood, Ohio
    Site status: Not listed — confirm with the team
  • Midwest Clinical Research Center
    Dayton, Ohio
    Site status: Not listed — confirm with the team
  • North Star Medical Research
    Middleburg Heights, Ohio
    Site status: Not listed — confirm with the team
  • Summit Headlands
    Portland, Oregon
    Site status: Not listed — confirm with the team
  • Coastal Carolina Research Center
    North Charleston, South Carolina
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • Donald J. Garcia, Jr, MD, PA
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Future Search Trials of Dallas
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Haracec Clinical Research
    El Paso, Texas
    Site status: Not listed — confirm with the team
  • Pillar Clinical Research
    Richardson, Texas
    Site status: Not listed — confirm with the team
  • R and H Clinical Research
    Stafford, Texas
    Site status: Not listed — confirm with the team
  • Grayline Research Center
    Wichita Falls, Texas
    Site status: Not listed — confirm with the team
  • Northwest Clinical Research Center
    Bellevue, Washington
    Site status: Not listed — confirm with the team
  • Core Clinical Research
    Everett, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving SP-624, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with depression; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Sirtsei Pharmaceuticals, Inc., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.